Academic Journal
Q1Genetics in Medicine
About Genetics in Medicine
Genetics in Medicine is a scholarly journal published by Elsevier B.V.. SCImago 2025 lists it in Q1, with an SJR of 2.687 and H-index of 176.
Coverage: 1998-2026. Research categories: Genetics (clinical) (Q1); Medicine (miscellaneous) (Q1).
Source-backed journal facts
Topics in published research
Genomics and Rare Diseases; BRCA gene mutations in cancer; Genomic variations and chromosomal abnormalities; Prenatal Screening and Diagnostics; Metabolism and Genetic Disorders; Genetic Associations and Epidemiology.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
5,110.00 USD; 4,780.00 EUR; 4,090.00 GBP; 633,790.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Cost-effectiveness of BRCA1/BRCA2 variant reclassification and recontact for hereditary breast and ovarian cancer in the United States
Gregory F. Guzauskas, Sara M. Berger, Robert O’Connor, Serra Kim et al.
2026-11 · DOI: 10.1016/j.gim.2026.102697Genomics-first association of pharmacogenomic risk phenotypes with adverse drug reactions in a healthcare–based population
Rebecca I. Torene, Ryley Uber, Tracy Brandt, Karyn Meltz Murphy et al.
2026-11 · DOI: 10.1016/j.gim.2026.102691Current status of genetic testing and mosaic variant assessment in somatic overgrowth and vascular anomalies: Insights from the Cancer Genomics Consortium Working Group
Avinash V. Dharmadhikari, Candace T. Myers, Katherine A. King, Bahareh Mojarad et al.
2026-11 · DOI: 10.1016/j.gim.2026.102686Disease characteristics of SEPSECS deficiency: An international, retrospective, multicenter cohort study
Benjamin Y. Killam, Maria J. Knol, Noelia Fradejas-Villar, Thilo S. Chillon et al.
2026-11 · DOI: 10.1016/j.gim.2026.102684The fetal fentanyl syndrome: Additional evidence in support of a new human teratogen
Álvaro Martín-Rodríguez, Adriana Gomes, Kristen Barbour, Kristen Wigby et al.
2026-11 · DOI: 10.1016/j.gim.2026.102698Patient and primary care clinician perspectives on polygenic risk scores for prostate cancer screening: A national qualitative study
Marla L. Clayman, Lilly Cheam, Christopher Gillespie, Ashley A. Antwi et al.
2026-11 · DOI: 10.1016/j.gim.2026.102696P-KNN: Joint calibration of multiple pathogenicity prediction tools streamlines variant classification
Po-Yu Lin, Nadav Brandes
2026-11 · DOI: 10.1016/j.gim.2026.102692Why atypical findings matter: Follow-up testing finds diagnostic results related to cfDNA screen
Rebekah Whitham, Hannah S. Anderson, Danielle LaGrave, Lauren Wallace et al.
2026-11 · DOI: 10.1016/j.gim.2026.102713Ethical concerns regarding genetic testing for Y chromosome presence in athletes: A position statement of the American College of Medical Genetics and Genomics (ACMG)
Eric Vilain, Mahmoud Aarabi, George Khushf, Svetlana Yatsenko et al.
2026-10 · DOI: 10.1016/j.gim.2026.102667Development of a simple clinical score to prioritize detection of severe α-1 antitrypsin deficiency with the PiZZ genotype
Yanzhen Cheng, Guillaume Butler-Laporte, Tomoko Nakanishi, Tianyuan Lu et al.
2026-10 · DOI: 10.1016/j.gim.2026.102690Mainstreaming genetic testing: Evaluation of the Australian Familial Melanoma Clinic
Jennifer Berkman, Clare Primiero, Centaine Snoswell, Courtney K. Wallingford et al.
2026-10 · DOI: 10.1016/j.gim.2026.102742Offering phone-based patient navigation to improve receipt of genetic testing for hereditary colorectal cancer: A pilot trial in an academic-affiliated health system
Sarah Knerr, Jacky Dahlquist, Marlana J. Kohn, Sarah Stayman et al.
2026-10 · DOI: 10.1016/j.gim.2026.102664KMT2A and KMT2B episignatures address diagnostic challenges associated with rare neurodevelopmental disorders
Zain Awamleh, Anthony Chen, Sanaa Choufani, Dmitrijs Rots et al.
2026-10 · DOI: 10.1016/j.gim.2026.102636CHARGE free cascade genetic testing: Effectiveness and implementation outcomes from a hybrid type I feasibility trial
Sukh Makhnoon, Nandana D. Rao, Grace Getchell, Yanete Rodriguez et al.
2026-10 · DOI: 10.1016/j.gim.2026.102721Characterization of the genotypic and phenotypic spectrum of TCF7L2-related neurodevelopmental disorder (TRND)
Sally Nijim, Mimi Kim, Melissa Denish, Michael V. Gonzalez et al.
2026-10 · DOI: 10.1016/j.gim.2026.102642Extended newborn screening using DNA methylation testing for fragile X syndrome in 17,107 infants
David E. Godler, Ling Ling, Dinusha Gamage, Minh Bui et al.
2026-10 · DOI: 10.1016/j.gim.2026.102646Rapid genome sequencing identifies treatable conditions in non–intensive care unit hospitalized children
Julie M. Porter, Rachel Palmquist, Chelsea Solorzano, Joshua L. Bonkowsky et al.
2026-10 · DOI: 10.1016/j.gim.2026.102683Short-term outcomes of a randomized, mixed-methods trial to improve disclosure of hereditary cancer test results and follow-up communication with family members
Deborah L. Cragun, Marleah Dean, Paige Phillips Hunt, Jason Beckstead et al.
2026-10 · DOI: 10.1016/j.gim.2026.102694Indigenous perspectives on biobanking, specimen storage, and data governance: A scoping review
Caleigh A. Curley, Adam Fernandez, Breanna Lameman, Alison A. Watson et al.
2026-10 · DOI: 10.1016/j.gim.2026.102641Identification of novel CDK19 variants and Drosophila-based in vivo functional evidence supporting pathogenicity in neurodevelopmental disorders
Hyun Yong Koh, Ranjan K. Sahu, Sung Dae Kim, Tomomi Tanaka et al.
2026-10 · DOI: 10.1016/j.gim.2026.102735Reviews
Community Reviews
Version History
September 18, 2026 at 2:15 am
September 18, 2026